.jpg?format=webp&width=780)
A recent study conducted on mice and human brain tissue suggests that a decrease in hypothalamic melanin-concentrating hormone (MCH) could be responsible for reduced food intake and weight loss in people with amyotrophic lateral sclerosis (ALS). The study sheds light on the metabolic dysregulation mechanisms of ALS and highlights the MCH pathway as a potential target for therapy.
Like
Save
Share